HomeNewsTechnologyAutoMercedes-Benz India H1 sales down 55% at 2,948 units

Mercedes-Benz India H1 sales down 55% at 2,948 units

The company had sold 6,561 units in the January-June period last year.

July 10, 2020 / 19:41 IST
Story continues below Advertisement

German luxury carmaker Mercedes-Benz on Friday reported a 55 percent decline in sales in the first half of the year at 2,948 units in India amid COVID-19 related challenges.

The company had sold 6,561 units in the January-June period last year.

Story continues below Advertisement

Mercedes-Benz India said it witnessed positive momentum in June 2020 sales, which showed first signs of a gradual recovery buoyed by a rejuvenated SUV portfolio that accounted for 57 percent of total sales in the month.

Commenting on the performance, Mercedes-Benz India Managing Director and CEO Martin Schwenk said, "We are glad to witness a slow movement from previous months and we expect this trend to gather momentum."

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show